Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000899243-22-035333
Filing Date
2022-11-07
Accepted
2022-11-07 21:50:26
Documents
1
Period of Report
2022-10-05

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 8838
  Complete submission text file 0000899243-22-035333.txt   10477
Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Issuer) CIK: 0001830214 (see all company filings)

EIN.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O SOARING EAGLE ACQUISITION CORP. 955 FIFTH AVENUE NEW YORK NY 10075
Business Address
Dmytruk Mark E. (Reporting) CIK: 0001873507 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-40097 | Film No.: 221367018